Navigation Links
DNA vaccine for ragweed allergies

A recent research reported that ragweed or hay fever symptoms could be reduced by 60% with the help of an experimental //DNA-based vaccine developed at Johns Hopkins in Baltimore.

Dr. Peter Socrates Creticos, medical director of the Johns Hopkins Asthma and Allergy Center at the Johns Hopkins University School of Medicine and his team tested the DNA vaccine during two fall ragweed seasons in Baltimore.

The study was conducted on 25 volunteers with known allergies to ragweed of the ages 23-60 years. In the first year of the study, 14 people were given six weekly injections of the new vaccine before the ragweed season began. The remaining 11 received six weekly injections of a placebo.

The symptoms like sneezing, runny nose, watery eyes, and itching had reduced by 60% in people who received the vaccine. This relief was found to be steady even in the second year without the administration of the vaccine.

The Immune Tolerance Network funded this study. The National Institute of Allergy and Infectious Diseases and the National Institute of Diabetes and Digestive and Kidney Diseases are supporting this network.

Dynavax Technologies Corp. of Berkeley, Calif manufactures this DNA-based vaccine. It comprises a DNA sequence obtained from bacteria to shut down the T-helper (Th2) cells that trigger the body's inflammatory immune responses.

The study has been published in the October 5 issue of the New England Journal of Medicine. Creticos said, "I don’t expect any serious long-term side effects because this vaccine restores normalcy. The vaccine is so specific, only targeting the ragweed allergy; there likely won't be any long-term adverse effects. In fact, the vaccine is so specific that people who were vaccinated and who also have grass allergies in the spring still experienced symptoms from that particular allergy. "

He said, "The next step for this vaccine is phase III trials, after which the vaccine c ould receive government approval if all goes well. It could potentially become commercially available a few years down the road."
GYT
'"/>




Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of ... of Pittsburgh points to eight genes that may explain why susceptibility to one of ... results of a study published today in the journal npj Schizophrenia. , “There ...
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of ... Center at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas ... easy access to Highway 121. , As the practice has grown, the need for ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals ... What You See” body image mannequin art competition. Selected from 15 submissions from around ... winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... again hosted their Military Wedding Giveaway, with the winning couple announced on Feb. ... with services generously donated from local vendors: A Matter of Taste, Ryan Rousseau ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... and Strategies - 2016" report to their offering. ... The latest research Autism ... pricing data and benchmarks in the global Autism Spectrum Disorder market. ... What are the key drugs marketed for Autism Spectrum Disorder ...
(Date:2/23/2017)... Limited, ( ASX: ITD ), an innovative diversified healthcare company, is ... December 2016 compared with the previous corresponding period. A full "Results ... . Highlights Profit after ... Earnings per share of 2.2 cents (Dec 2015: 1.2 cents; up ... 11%) Profit before tax of $2.12m (Dec 2015: ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology: